Our previous studies demonstrate that LCN2 plays an inflammatory role in the WAT, liver, and hippocampus in animal models of metabolic disorders, including obesity, non-alcoholic fatty liver disease, and T2D [4,8,18]. The gene discussed is LCN2; the disease is metabolic dysfunction-associated steatotic liver disease.